Form 4 for OCGN Ocugen, Inc.
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-16 · accession 0001104659-21-151343 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-12-17 | 2021-12-16 | OCGN | Musunuri Shankar | CEO, Dir | S - Sale | $5.22 | -115.0K | 1.15M | -9% | -$600.3K |
| D | 2021-12-17 | 2021-12-16 | OCGN | Musunuri Shankar | CEO, Dir | A - Grant | $0.00 | +197.0K | 394.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | S | D | 115,000 | $5.22 | 1,145,299 | I By: KVM Holdings, LLC | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.03 to $5.39. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F3) The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC. |
| 2 | Derivative | Option (Right to Buy) | 2021-12-16 | A | A | 197,000 | $0.00 | 394,000 | D | $5.64 · — to 2031-04-19 | 197,000 Common Stock | (F6) On December 16, 2021, the Compensation Committee determined that the second performance criteria had been achieved, resulting in the Performance-Based Option vesting in part as to 197,000 shares. 98,500 shares of the Performance-Based Option are immediately vested and exercisable, with the remaining 98,500 shares vesting on December 16, 2022, subject to the Reporting Person's continued service with the Company. (F5) On April 19, 2021, the Reporting Person was granted a performance-based option to purchase 985,000 shares of the Company's common stock based on the Company's satisfaction of five performance criteria prior to the end of the Company's 2021 and 2022 fiscal years, as applicable (the "Performance-Based Option"). With respect to each performance criteria, 10% of the Performance-Based Option vests on the date of the Compensation Committee's determination that the applicable criteria has been achieved (each, a "Determination Date") and an additional 10% vests upon the first anniversary of the applicable Determination Date, subject to the grantee's continued service with the Company on such date. (F4) Represents the closing price of the Company's common stock on the date of grant. See footnote 5 & 6 below. |